These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 37052520)
41. Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells. Vooijs M; te Riele H; van der Valk M; Berns A Oncogene; 2002 Jul; 21(30):4635-45. PubMed ID: 12096340 [TBL] [Abstract][Full Text] [Related]
43. Genome maintenance in retinoblastoma: Implications for therapeutic vulnerabilities. Lee C; Kim JK Oncol Lett; 2022 Jun; 23(6):192. PubMed ID: 35527780 [TBL] [Abstract][Full Text] [Related]
44. Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression. Benavente CA; Finkelstein D; Johnson DA; Marine JC; Ashery-Padan R; Dyer MA Oncotarget; 2014 Oct; 5(20):9594-608. PubMed ID: 25338120 [TBL] [Abstract][Full Text] [Related]
45. Compensation by tumor suppressor genes during retinal development in mice and humans. Donovan SL; Schweers B; Martins R; Johnson D; Dyer MA BMC Biol; 2006 May; 4():14. PubMed ID: 16672052 [TBL] [Abstract][Full Text] [Related]
46. Identification of high-risk human papillomavirus and Rb/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma. Shamir ER; Devine WP; Pekmezci M; Umetsu SE; Krings G; Federman S; Cho SJ; Saunders TA; Jen KY; Bergsland E; Jones K; Kim GE; Kakar S; Chiu CY; Joseph NM Mod Pathol; 2019 Feb; 32(2):290-305. PubMed ID: 30237525 [TBL] [Abstract][Full Text] [Related]
47. Blee AM; He Y; Yang Y; Ye Z; Yan Y; Pan Y; Ma T; Dugdale J; Kuehn E; Kohli M; Jimenez R; Chen Y; Xu W; Wang L; Huang H Clin Cancer Res; 2018 Sep; 24(18):4551-4565. PubMed ID: 29844131 [No Abstract] [Full Text] [Related]
48. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. Mu P; Zhang Z; Benelli M; Karthaus WR; Hoover E; Chen CC; Wongvipat J; Ku SY; Gao D; Cao Z; Shah N; Adams EJ; Abida W; Watson PA; Prandi D; Huang CH; de Stanchina E; Lowe SW; Ellis L; Beltran H; Rubin MA; Goodrich DW; Demichelis F; Sawyers CL Science; 2017 Jan; 355(6320):84-88. PubMed ID: 28059768 [TBL] [Abstract][Full Text] [Related]
49. Intersection of retinoblastoma tumor suppressor function, stem cells, metabolism, and inflammation. Kitajima S; Takahashi C Cancer Sci; 2017 Sep; 108(9):1726-1731. PubMed ID: 28865172 [TBL] [Abstract][Full Text] [Related]
50. Identification of Epigenetically Modified Hub Genes and Altered Pathways Associated With Retinoblastoma. Karmakar A; Ahamad Khan MM; Kumari N; Devarajan N; Ganesan SK Front Cell Dev Biol; 2022; 10():743224. PubMed ID: 35359459 [TBL] [Abstract][Full Text] [Related]
51. Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic Kras and impairs senescence in premalignant lesions. Carrière C; Gore AJ; Norris AM; Gunn JR; Young AL; Longnecker DS; Korc M Gastroenterology; 2011 Sep; 141(3):1091-101. PubMed ID: 21699781 [TBL] [Abstract][Full Text] [Related]
52. The RB-IL-6 axis controls self-renewal and endocrine therapy resistance by fine-tuning mitochondrial activity. Kitajima S; Yoshida A; Kohno S; Li F; Suzuki S; Nagatani N; Nishimoto Y; Sasaki N; Muranaka H; Wan Y; Thai TC; Okahashi N; Matsuda F; Shimizu H; Nishiuchi T; Suzuki Y; Tominaga K; Gotoh N; Suzuki M; Ewen ME; Barbie DA; Hirose O; Tanaka T; Takahashi C Oncogene; 2017 Sep; 36(36):5145-5157. PubMed ID: 28481867 [TBL] [Abstract][Full Text] [Related]
54. Targeted pharmacologic inhibition of S-phase kinase-associated protein 2 (SKP2) mediated cell cycle regulation in lung and other RB-Related cancers: A brief review of current status and future prospects. Elahi AH; Morales CS; Xu XL; Eliades A; Patsalis PC; Abramson DH; Jhanwar SC Adv Biol Regul; 2023 May; 88():100964. PubMed ID: 37004354 [TBL] [Abstract][Full Text] [Related]
55. Profiling genomic copy number changes in retinoblastoma beyond loss of RB1. Bowles E; Corson TW; Bayani J; Squire JA; Wong N; Lai PB; Gallie BL Genes Chromosomes Cancer; 2007 Feb; 46(2):118-29. PubMed ID: 17099872 [TBL] [Abstract][Full Text] [Related]
56. Functional genomics identifies new synergistic therapies for retinoblastoma. Aubry A; Pearson JD; Huang K; Livne-Bar I; Ahmad M; Jagadeesan M; Khetan V; Ketela T; Brown KR; Yu T; Lu S; Wrana JL; Moffat J; Bremner R Oncogene; 2020 Jul; 39(31):5338-5357. PubMed ID: 32572160 [TBL] [Abstract][Full Text] [Related]
57. Role of RB and RB2/P130 genes in marrow stromal stem cells plasticity. Jori FP; Napolitano MA; Melone MA; Cipollaro M; Cascino A; Giordano A; Galderisi U J Cell Physiol; 2004 Aug; 200(2):201-12. PubMed ID: 15174090 [TBL] [Abstract][Full Text] [Related]
58. Lineage Plasticity: The New Cancer Hallmark on the Block. Mehta A; Stanger BZ Cancer Res; 2024 Jan; 84(2):184-191. PubMed ID: 37963209 [TBL] [Abstract][Full Text] [Related]
59. Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells. Sharma A; Comstock CE; Knudsen ES; Cao KH; Hess-Wilson JK; Morey LM; Barrera J; Knudsen KE Cancer Res; 2007 Jul; 67(13):6192-203. PubMed ID: 17616676 [TBL] [Abstract][Full Text] [Related]